1. Home
  2. LGVN vs BRLT Comparison

LGVN vs BRLT Comparison

Compare LGVN & BRLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • BRLT
  • Stock Information
  • Founded
  • LGVN 2014
  • BRLT 2005
  • Country
  • LGVN United States
  • BRLT United States
  • Employees
  • LGVN N/A
  • BRLT N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • BRLT Consumer Specialties
  • Sector
  • LGVN Health Care
  • BRLT Consumer Discretionary
  • Exchange
  • LGVN Nasdaq
  • BRLT Nasdaq
  • Market Cap
  • LGVN 28.4M
  • BRLT 27.2M
  • IPO Year
  • LGVN 2021
  • BRLT 2021
  • Fundamental
  • Price
  • LGVN $1.65
  • BRLT $1.95
  • Analyst Decision
  • LGVN Strong Buy
  • BRLT Buy
  • Analyst Count
  • LGVN 3
  • BRLT 4
  • Target Price
  • LGVN $8.67
  • BRLT $3.00
  • AVG Volume (30 Days)
  • LGVN 307.8K
  • BRLT 80.0K
  • Earning Date
  • LGVN 11-12-2024
  • BRLT 11-07-2024
  • Dividend Yield
  • LGVN N/A
  • BRLT N/A
  • EPS Growth
  • LGVN N/A
  • BRLT N/A
  • EPS
  • LGVN N/A
  • BRLT 0.03
  • Revenue
  • LGVN $1,852,000.00
  • BRLT $426,982,000.00
  • Revenue This Year
  • LGVN $161.78
  • BRLT N/A
  • Revenue Next Year
  • LGVN $40.89
  • BRLT $2.47
  • P/E Ratio
  • LGVN N/A
  • BRLT $70.97
  • Revenue Growth
  • LGVN 141.46
  • BRLT N/A
  • 52 Week Low
  • LGVN $0.77
  • BRLT $1.52
  • 52 Week High
  • LGVN $21.30
  • BRLT $3.81
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 31.55
  • BRLT 54.22
  • Support Level
  • LGVN $1.80
  • BRLT $1.93
  • Resistance Level
  • LGVN $2.15
  • BRLT $2.04
  • Average True Range (ATR)
  • LGVN 0.13
  • BRLT 0.12
  • MACD
  • LGVN -0.03
  • BRLT 0.00
  • Stochastic Oscillator
  • LGVN 0.00
  • BRLT 64.86

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About BRLT Brilliant Earth Group Inc.

Brilliant Earth Group Inc designs, procures and sells ethically-sourced diamonds, gemstones and jewelry online and through showrooms. Its sales consist of revenue from diamond, gemstone, and jewelry retail sales. The company sells its products in the U.S. and other international countries, of which a majority of revenue is derived from the U.S.

Share on Social Networks: